NEW YORK, NY, UNITED STATES, October 22, 2024 /EINPresswire.com/ -- Celmatix Inc., the leading women's health biotechnology company focused on ovarian biology, has announced the nomination of a lead compound in its oral Follicle Stimulating Hormone ...